Trials / Sponsors / GI Innovation, Inc.
GI Innovation, Inc.
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Effects of the Combination of GI-102 With GIB-7 on Biomarkers of Aging in Healthy Adul Cancer Survivors, Healthy Participant, Elderly | Phase 2 | 2026-01-01 |
| Recruiting | A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advan Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Cancer (NSCLC) | Phase 1 / Phase 2 | 2025-04-22 |
| Recruiting | A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Co Advanced Solid Tumor, Metastatic Solid Tumor, Soft Tissue Sarcoma (STS) | Phase 1 / Phase 2 | 2023-05-30 |
| Recruiting | GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors Advanced Solid Tumor, Metastatic Solid Tumor, Cervical Cancer | Phase 1 / Phase 2 | 2021-08-02 |